Vladimir Lerner

Original Research

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

Original Research

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

Original Research

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Original Research

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Original Research

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

Letter to the Editor

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

Letter to the Editor

Nefazodone-Associated Subjective Complaints of Burning Sensations

Original Research

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

Original Research

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

Original Research

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

Original Research

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

Original Research

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

Nefazodone-Associated Subjective Complaints of Burning Sensations

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

ELSEWHERE:

FOLLOW US:

Vladimir Lerner

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

Nefazodone-Associated Subjective Complaints of Burning Sensations

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles